Global In-vitro Toxicology Testing Market Growth (Status and Outlook) 2024-2030

In 2023, the In-vitro Toxicology Testing market reached USD 10.33 billion, propelled by increasing regulatory scrutiny and the adoption of non-animal testing methods in pharmaceuti

According to our publisher latest study, the global In-vitro Toxicology Testing market size was valued at US$ 10330 million in 2023. With growing demand in downstream market, the In-vitro Toxicology Testing is forecast to a readjusted size of US$ 16280 million by 2030 with a CAGR of 6.7% during review period. The research report highlights the growth potential of the global In-vitro Toxicology Testing market. In-vitro Toxicology Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of In-vitro Toxicology Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the In-vitro Toxicology Testing market.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

In-vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. Significant progress in toxicology science is one of the key trends escalating market growth. Besides this, socio-ethical concerns pertaining to animal tests and high costs associated with conventional animal tests are poised to boost the inclination towards in-vitro toxicology assays. Key Features:

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

The report on In-vitro Toxicology Testing market reflects various aspects and provide valuable insights into the industry. Market Size and Growth: The research report provide an overview of the current size and growth of the In-vitro Toxicology Testing market. It may include historical data, market segmentation by Type (e.g., Cellular Assay, Biochemical Assay), and regional breakdowns. Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the In-vitro Toxicology Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs. Market Drivers: 1. Regulatory Requirements: Stringent regulations governing chemical safety and toxicity testing drive the demand for in-vitro toxicology testing methods. Regulatory agencies worldwide require comprehensive toxicological data to assess the safety and efficacy of pharmaceuticals, chemicals, cosmetics, and food additives, leading to increased adoption of in-vitro testing methods. 2. Ethical and Animal Welfare Concerns: Growing concerns over animal welfare and ethical considerations in scientific research drive the shift towards in-vitro testing methods as alternatives to animal testing. In-vitro assays offer ethical advantages by reducing or eliminating the need for animal experimentation, aligning with societal values and regulatory mandates focused on minimizing animal use in research. 3. Advancements in Technology: Technological advancements in cell culture techniques, high-throughput screening platforms, and predictive modeling algorithms enhance the capabilities and accuracy of in-vitro toxicology testing methods. Innovations such as 3D cell culture models, organ-on-chip technologies, and multi-parametric assays enable more physiologically relevant and predictive toxicity assessments. 4. Cost and Time Efficiency: In-vitro toxicology testing methods offer cost and time efficiencies compared to traditional animal testing approaches. In-vitro assays require fewer resources, less time, and lower costs to conduct experiments, analyze results, and generate toxicological data, making them attractive options for pharmaceutical companies, chemical manufacturers, and regulatory agencies seeking cost-effective testing solutions. 5. Drug Development Pipeline: The increasing complexity and diversity of drug candidates in the pharmaceutical industry drive the demand for in-vitro toxicology testing services. Pharmaceutical companies rely on in-vitro assays to screen drug candidates for potential toxic effects, predict adverse drug reactions, and prioritize compounds for further preclinical and clinical development stages, accelerating the drug discovery and development process. Challenges: 1. Standardization and Validation: Standardizing in-vitro toxicology testing methods and ensuring their reliability, reproducibility, and regulatory acceptance pose challenges for the industry. Variability in assay protocols, cell lines, culture conditions, and endpoint measurements can impact the consistency and validity of test results, requiring rigorous validation studies and harmonization efforts to establish standardized protocols. 2. Complexity of Biological Systems: The complexity of biological systems and inter-individual variability present challenges for in-vitro toxicology testing. Cell-based assays may not fully capture the complexity of human physiology, metabolism, and toxicological responses observed in vivo, leading to limitations in predicting real-world outcomes and translating in-vitro data to in vivo relevance. 3. Validation and Acceptance by Regulatory Agencies: Achieving regulatory acceptance of in-vitro toxicology testing methods requires validation studies to demonstrate their accuracy, sensitivity, specificity, and relevance compared to traditional animal testing approaches. Regulatory agencies may require extensive validation data and acceptance criteria for in-vitro assays to replace or supplement animal testing in regulatory submissions. 4. Data Interpretation and Integration: Interpreting and integrating complex data generated from in-vitro toxicology testing assays pose challenges for researchers and regulatory evaluators. Analyzing multi-parametric datasets, identifying relevant biomarkers, and correlating in-vitro results with in vivo outcomes require advanced data analysis tools, bioinformatics expertise, and mechanistic understanding of toxicological pathways. 5. Market Fragmentation and Competition: The global in-vitro toxicology testing market is fragmented, with numerous companies offering a wide range of testing services, assay kits, and platforms. Intense competition, pricing pressures, and commoditization of in-vitro assays pose challenges for companies to differentiate their offerings, establish market presence, and capture market share in the competitive landscape. Trends: 1. Shift Towards 3D Cell Culture Models: The adoption of 3D cell culture models, organoids, and microphysiological systems (organ-on-chip) is gaining traction in in-vitro toxicology testing. These advanced models better mimic the complexity and functionality of human tissues and organs, offering improved physiological relevance and predictive capabilities for toxicity assessment. 2. Integration of High-Throughput Screening (HTS) Technologies: High-throughput screening technologies enable the rapid screening of large compound libraries for toxicological profiling and safety assessment. Integrating HTS platforms with in-vitro toxicology testing assays enables faster, more efficient, and cost-effective screening of chemical compounds, accelerating drug discovery and safety evaluation processes. 3. Advancements in Predictive Toxicology Modeling: Predictive toxicology modeling approaches, including quantitative structure-activity relationship (QSAR) modeling, machine learning algorithms, and computational toxicology tools, are advancing the prediction of chemical toxicity and safety profiles. These modeling techniques complement experimental in-vitro assays, providing valuable insights into structure-activity relationships, toxicity mechanisms, and risk assessment. 4. Focus on Multi-Organ Systems and Toxicity Pathways: Multi-organ systems and integrated toxicity platforms that model interactions between different organs and physiological systems are emerging as promising tools for in-vitro toxicology testing. These systems enable the evaluation of systemic toxicity, organ cross-talk, and adverse outcome pathways (AOPs), enhancing the understanding of complex toxicity mechanisms and drug-induced adverse effects. 5. Expansion of Applications Beyond Pharmaceuticals: Beyond the pharmaceutical industry, in-vitro toxicology testing techniques are finding use in a variety of other industries, including chemicals, cosmetics, food additives, and environmental toxicology. The use of in-vitro assays for risk management, hazard detection, and chemical safety evaluation is being driven by regulatory initiatives, customer demand for safer products, and sustainability considerations in a variety of industries. Competitive Landscape: The research report provides analysis of the competitive landscape within the In-vitro Toxicology Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Technological Developments: The research report can delve into the latest technological developments in the In-vitro Toxicology Testing industry. This include advancements in In-vitro Toxicology Testing technology, In-vitro Toxicology Testing new entrants, In-vitro Toxicology Testing new investment, and other innovations that are shaping the future of In-vitro Toxicology Testing. Technological developments in the field of in-vitro toxicology testing are driving innovation and improving the accuracy, efficiency, and predictive capabilities of testing methods. Here are some key technological advancements: 1. Advanced Cell Culture Techniques: Technological advancements in cell culture techniques, such as 3D cell culture models, organoids, and co-culture systems, enable more physiologically relevant and complex in-vitro models. These advanced cell culture techniques better mimic the structure, function, and interactions of human tissues and organs, improving the predictive capabilities of toxicity testing assays. 2. Microfluidic Platforms and Organ-on-Chip Technology: Microfluidic platforms and organ-on-chip technology enable the creation of miniaturized, microengineered systems that replicate the physiological functions of human organs and tissues. Organ-on-chip devices provide dynamic microenvironments, perfusion flow, and cellular interactions, allowing for more accurate and dynamic toxicity testing under controlled conditions. 3. High-Throughput Screening (HTS) Systems: High-throughput screening (HTS) systems enable the rapid screening of large compound libraries for toxicity assessment. Automated HTS platforms, robotics, and liquid handling systems facilitate the screening of thousands of chemical compounds simultaneously, accelerating the identification of potential toxicants and prioritization of compounds for further testing. 4. Omics Technologies: Omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, provide comprehensive insights into cellular responses to toxicants at the molecular level. These technologies enable the identification of biomarkers, mechanistic pathways, and toxicity signatures associated with chemical exposure, facilitating the development of predictive toxicity models and personalized risk assessment approaches. 5. Computational Toxicology and Predictive Modeling: Computational toxicology approaches, such as quantitative structure-activity relationship (QSAR) modeling, machine learning algorithms, and in silico modeling, enable the prediction of chemical toxicity and safety profiles based on chemical structure, physicochemical properties, and biological activity. Predictive modeling tools complement experimental in-vitro assays, providing valuable insights into toxicity mechanisms and hazard assessment. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the In-vitro Toxicology Testing market. It includes factors influencing customer ' purchasing decisions, preferences for In-vitro Toxicology Testing product. Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the In-vitro Toxicology Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting In-vitro Toxicology Testing market. The report also evaluates the effectiveness of these policies in driving market growth. Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the In-vitro Toxicology Testing market. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the In-vitro Toxicology Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the In-vitro Toxicology Testing market. Recommendations: 1. Invest in Advanced Technologies: Allocate resources towards adopting and integrating advanced technologies such as 3D cell culture models, organ-on-chip devices, high-throughput screening (HTS) systems, and omics technologies into in-vitro toxicology testing workflows. Invest in training and expertise development to leverage these technologies effectively and enhance the predictive capabilities of toxicity testing assays. 2. Collaborate with Academic and Research Institutions: Foster collaborations with academic and research institutions to access cutting-edge technologies, expertise, and resources in in-vitro toxicology research. Collaborative research projects, joint ventures, and technology transfer agreements can accelerate innovation, drive scientific advancements, and expand the capabilities of in-vitro testing methods. 3. Offer Customized Testing Services: Develop customized in-vitro toxicology testing services tailored to the specific needs and requirements of clients in pharmaceuticals, chemicals, cosmetics, and consumer product industries. Offer flexible testing options, assay customization, and consulting services to address diverse toxicological endpoints, regulatory requirements, and product safety concerns. 4. Enhance Data Integration and Analysis: Strengthen data integration and analysis capabilities to derive actionable insights from large-scale omics data, high-content imaging datasets, and multi-parametric toxicity profiles generated from in-vitro assays. Invest in bioinformatics tools, data visualization platforms, and machine learning algorithms to streamline data analysis, identify toxicity biomarkers, and predict adverse outcomes more accurately. Opportunities: 1. Expansion into Emerging Markets: Explore opportunities to expand into emerging markets with growing demand for in-vitro toxicology testing services and regulatory compliance requirements. Target regions with increasing investments in pharmaceuticals, chemicals, and consumer products, and collaborate with local regulatory agencies, contract research organizations (CROs), and industry associations to establish market presence and meet regulatory needs. 2. Diversification of Testing Applications: Diversify testing applications beyond traditional pharmaceutical and chemical safety assessments to include areas such as cosmetics, personal care products, food additives, and environmental toxicology. Develop specialized testing services for niche markets, emerging contaminants, and novel product categories, addressing evolving consumer preferences and regulatory trends. 3. Focus on Sustainability and Green Chemistry: Capitalize on growing awareness of sustainability and environmental stewardship by offering green chemistry-based toxicity testing services. Develop eco-friendly assays, bioassays, and alternative testing methods that reduce reliance on animal experimentation, minimize chemical usage, and promote the development of safer and more sustainable products. 4. Strategic Partnerships and Collaborations: Establish strategic alliances and cooperative efforts with industry players, regulatory bodies, and technology suppliers to capitalize on complementary proficiencies, assets, and capacities in in vitro toxicological assessment. Work together on research initiatives, consortiums, and consortia to solve shared problems, increase scientific understanding, and spur toxicity testing technique improvement. Market Segmentation: In-vitro Toxicology Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Segmentation by type Cellular Assay Biochemical Assay In Silica Ex-vivo Segmentation by application Systemic Toxicology Dermal Toxicity Endocrine Disruption Ocular Toxicity Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Abbott Covance GE Healthcare Quest Diagnostics Inc. Thermo Fisher Scientific Inc. Bio-Rad Laboratories Catalent Pharma Solutions Cyprotex Agilent Technologies Charles River Laboratories Merck KgaA Eurofins Scientific Inc.

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global In-vitro Toxicology Testing Market Size 2019-2030
  • 2.1.2 In-vitro Toxicology Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
  • 2.2 In-vitro Toxicology Testing Segment by Type
  • 2.2.1 Cellular Assay
  • 2.2.2 Biochemical Assay
  • 2.2.3 In Silica
  • 2.2.4 Ex-vivo
  • 2.3 In-vitro Toxicology Testing Market Size by Type
  • 2.3.1 In-vitro Toxicology Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
  • 2.3.2 Global In-vitro Toxicology Testing Market Size Market Share by Type (2019-2024)
  • 2.4 In-vitro Toxicology Testing Segment by Application
  • 2.4.1 Systemic Toxicology
  • 2.4.2 Dermal Toxicity
  • 2.4.3 Endocrine Disruption
  • 2.4.4 Ocular Toxicity
  • 2.4.5 Others
  • 2.5 In-vitro Toxicology Testing Market Size by Application
  • 2.5.1 In-vitro Toxicology Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
  • 2.5.2 Global In-vitro Toxicology Testing Market Size Market Share by Application (2019-2024)
  • 3 In-vitro Toxicology Testing Market Size by Player
  • 3.1 In-vitro Toxicology Testing Market Size Market Share by Players
  • 3.1.1 Global In-vitro Toxicology Testing Revenue by Players (2019-2024)
  • 3.1.2 Global In-vitro Toxicology Testing Revenue Market Share by Players (2019-2024)
  • 3.2 Global In-vitro Toxicology Testing Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion
  • 4 In-vitro Toxicology Testing by Regions
  • 4.1 In-vitro Toxicology Testing Market Size by Regions (2019-2024)
  • 4.2 Americas In-vitro Toxicology Testing Market Size Growth (2019-2024)
  • 4.3 APAC In-vitro Toxicology Testing Market Size Growth (2019-2024)
  • 4.4 Europe In-vitro Toxicology Testing Market Size Growth (2019-2024)
  • 4.5 Middle East & Africa In-vitro Toxicology Testing Market Size Growth (2019-2024)
  • 5 Americas
  • 5.1 Americas In-vitro Toxicology Testing Market Size by Country (2019-2024)
  • 5.2 Americas In-vitro Toxicology Testing Market Size by Type (2019-2024)
  • 5.3 Americas In-vitro Toxicology Testing Market Size by Application (2019-2024)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC In-vitro Toxicology Testing Market Size by Region (2019-2024)
  • 6.2 APAC In-vitro Toxicology Testing Market Size by Type (2019-2024)
  • 6.3 APAC In-vitro Toxicology Testing Market Size by Application (2019-2024)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 7 Europe
  • 7.1 Europe In-vitro Toxicology Testing by Country (2019-2024)
  • 7.2 Europe In-vitro Toxicology Testing Market Size by Type (2019-2024)
  • 7.3 Europe In-vitro Toxicology Testing Market Size by Application (2019-2024)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa In-vitro Toxicology Testing by Region (2019-2024)
  • 8.2 Middle East & Africa In-vitro Toxicology Testing Market Size by Type (2019-2024)
  • 8.3 Middle East & Africa In-vitro Toxicology Testing Market Size by Application (2019-2024)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Global In-vitro Toxicology Testing Market Forecast
  • 10.1 Global In-vitro Toxicology Testing Forecast by Regions (2025-2030)
  • 10.1.1 Global In-vitro Toxicology Testing Forecast by Regions (2025-2030)
  • 10.1.2 Americas In-vitro Toxicology Testing Forecast
  • 10.1.3 APAC In-vitro Toxicology Testing Forecast
  • 10.1.4 Europe In-vitro Toxicology Testing Forecast
  • 10.1.5 Middle East & Africa In-vitro Toxicology Testing Forecast
  • 10.2 Americas In-vitro Toxicology Testing Forecast by Country (2025-2030)
  • 10.2.1 United States In-vitro Toxicology Testing Market Forecast
  • 10.2.2 Canada In-vitro Toxicology Testing Market Forecast
  • 10.2.3 Mexico In-vitro Toxicology Testing Market Forecast
  • 10.2.4 Brazil In-vitro Toxicology Testing Market Forecast
  • 10.3 APAC In-vitro Toxicology Testing Forecast by Region (2025-2030)
  • 10.3.1 China In-vitro Toxicology Testing Market Forecast
  • 10.3.2 Japan In-vitro Toxicology Testing Market Forecast
  • 10.3.3 Korea In-vitro Toxicology Testing Market Forecast
  • 10.3.4 Southeast Asia In-vitro Toxicology Testing Market Forecast
  • 10.3.5 India In-vitro Toxicology Testing Market Forecast
  • 10.3.6 Australia In-vitro Toxicology Testing Market Forecast
  • 10.4 Europe In-vitro Toxicology Testing Forecast by Country (2025-2030)
  • 10.4.1 Germany In-vitro Toxicology Testing Market Forecast
  • 10.4.2 France In-vitro Toxicology Testing Market Forecast
  • 10.4.3 UK In-vitro Toxicology Testing Market Forecast
  • 10.4.4 Italy In-vitro Toxicology Testing Market Forecast
  • 10.4.5 Russia In-vitro Toxicology Testing Market Forecast
  • 10.5 Middle East & Africa In-vitro Toxicology Testing Forecast by Region (2025-2030)
  • 10.5.1 Egypt In-vitro Toxicology Testing Market Forecast
  • 10.5.2 South Africa In-vitro Toxicology Testing Market Forecast
  • 10.5.3 Israel In-vitro Toxicology Testing Market Forecast
  • 10.5.4 Turkey In-vitro Toxicology Testing Market Forecast
  • 10.5.5 GCC Countries In-vitro Toxicology Testing Market Forecast
  • 10.6 Global In-vitro Toxicology Testing Forecast by Type (2025-2030)
  • 10.7 Global In-vitro Toxicology Testing Forecast by Application (2025-2030)
  • 11 Key Players Analysis
  • 11.1 Abbott
  • 11.1.1 Abbott Company Information
  • 11.1.2 Abbott In-vitro Toxicology Testing Product Offered
  • 11.1.3 Abbott In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.1.4 Abbott Main Business Overview
  • 11.1.5 Abbott Latest Developments
  • 11.2 Covance
  • 11.2.1 Covance Company Information
  • 11.2.2 Covance In-vitro Toxicology Testing Product Offered
  • 11.2.3 Covance In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.2.4 Covance Main Business Overview
  • 11.2.5 Covance Latest Developments
  • 11.3 GE Healthcare
  • 11.3.1 GE Healthcare Company Information
  • 11.3.2 GE Healthcare In-vitro Toxicology Testing Product Offered
  • 11.3.3 GE Healthcare In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.3.4 GE Healthcare Main Business Overview
  • 11.3.5 GE Healthcare Latest Developments
  • 11.4 Quest Diagnostics Inc.
  • 11.4.1 Quest Diagnostics Inc. Company Information
  • 11.4.2 Quest Diagnostics Inc. In-vitro Toxicology Testing Product Offered
  • 11.4.3 Quest Diagnostics Inc. In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.4.4 Quest Diagnostics Inc. Main Business Overview
  • 11.4.5 Quest Diagnostics Inc. Latest Developments
  • 11.5 Thermo Fisher Scientific Inc.
  • 11.5.1 Thermo Fisher Scientific Inc. Company Information
  • 11.5.2 Thermo Fisher Scientific Inc. In-vitro Toxicology Testing Product Offered
  • 11.5.3 Thermo Fisher Scientific Inc. In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.5.4 Thermo Fisher Scientific Inc. Main Business Overview
  • 11.5.5 Thermo Fisher Scientific Inc. Latest Developments
  • 11.6 Bio-Rad Laboratories
  • 11.6.1 Bio-Rad Laboratories Company Information
  • 11.6.2 Bio-Rad Laboratories In-vitro Toxicology Testing Product Offered
  • 11.6.3 Bio-Rad Laboratories In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.6.4 Bio-Rad Laboratories Main Business Overview
  • 11.6.5 Bio-Rad Laboratories Latest Developments
  • 11.7 Catalent Pharma Solutions
  • 11.7.1 Catalent Pharma Solutions Company Information
  • 11.7.2 Catalent Pharma Solutions In-vitro Toxicology Testing Product Offered
  • 11.7.3 Catalent Pharma Solutions In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.7.4 Catalent Pharma Solutions Main Business Overview
  • 11.7.5 Catalent Pharma Solutions Latest Developments
  • 11.8 Cyprotex
  • 11.8.1 Cyprotex Company Information
  • 11.8.2 Cyprotex In-vitro Toxicology Testing Product Offered
  • 11.8.3 Cyprotex In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.8.4 Cyprotex Main Business Overview
  • 11.8.5 Cyprotex Latest Developments
  • 11.9 Agilent Technologies
  • 11.9.1 Agilent Technologies Company Information
  • 11.9.2 Agilent Technologies In-vitro Toxicology Testing Product Offered
  • 11.9.3 Agilent Technologies In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.9.4 Agilent Technologies Main Business Overview
  • 11.9.5 Agilent Technologies Latest Developments
  • 11.10 Charles River Laboratories
  • 11.10.1 Charles River Laboratories Company Information
  • 11.10.2 Charles River Laboratories In-vitro Toxicology Testing Product Offered
  • 11.10.3 Charles River Laboratories In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.10.4 Charles River Laboratories Main Business Overview
  • 11.10.5 Charles River Laboratories Latest Developments
  • 11.11 Merck KgaA
  • 11.11.1 Merck KgaA Company Information
  • 11.11.2 Merck KgaA In-vitro Toxicology Testing Product Offered
  • 11.11.3 Merck KgaA In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.11.4 Merck KgaA Main Business Overview
  • 11.11.5 Merck KgaA Latest Developments
  • 11.12 Eurofins Scientific Inc.
  • 11.12.1 Eurofins Scientific Inc. Company Information
  • 11.12.2 Eurofins Scientific Inc. In-vitro Toxicology Testing Product Offered
  • 11.12.3 Eurofins Scientific Inc. In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2024)
  • 11.12.4 Eurofins Scientific Inc. Main Business Overview
  • 11.12.5 Eurofins Scientific Inc. Latest Developments
  • 12 Research Findings and Conclusion

Table 1. In-vitro Toxicology Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of Cellular Assay Table 3. Major Players of Biochemical Assay Table 4. Major Players of In Silica Table 5. Major Players of Ex-vivo Table 6. In-vitro Toxicology Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 7. Global In-vitro Toxicology Testing Market Size by Type (2019-2024) & ($ Millions) Table 8. Global In-vitro Toxicology Testing Market Size Market Share by Type (2019-2024) Table 9. In-vitro Toxicology Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 10. Global In-vitro Toxicology Testing Market Size by Application (2019-2024) & ($ Millions) Table 11. Global In-vitro Toxicology Testing Market Size Market Share by Application (2019-2024) Table 12. Global In-vitro Toxicology Testing Revenue by Players (2019-2024) & ($ Millions) Table 13. Global In-vitro Toxicology Testing Revenue Market Share by Player (2019-2024) Table 14. In-vitro Toxicology Testing Key Players Head office and Products Offered Table 15. In-vitro Toxicology Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global In-vitro Toxicology Testing Market Size by Regions 2019-2024 & ($ Millions) Table 19. Global In-vitro Toxicology Testing Market Size Market Share by Regions (2019-2024) Table 20. Global In-vitro Toxicology Testing Revenue by Country/Region (2019-2024) & ($ millions) Table 21. Global In-vitro Toxicology Testing Revenue Market Share by Country/Region (2019-2024) Table 22. Americas In-vitro Toxicology Testing Market Size by Country (2019-2024) & ($ Millions) Table 23. Americas In-vitro Toxicology Testing Market Size Market Share by Country (2019-2024) Table 24. Americas In-vitro Toxicology Testing Market Size by Type (2019-2024) & ($ Millions) Table 25. Americas In-vitro Toxicology Testing Market Size Market Share by Type (2019-2024) Table 26. Americas In-vitro Toxicology Testing Market Size by Application (2019-2024) & ($ Millions) Table 27. Americas In-vitro Toxicology Testing Market Size Market Share by Application (2019-2024) Table 28. APAC In-vitro Toxicology Testing Market Size by Region (2019-2024) & ($ Millions) Table 29. APAC In-vitro Toxicology Testing Market Size Market Share by Region (2019-2024) Table 30. APAC In-vitro Toxicology Testing Market Size by Type (2019-2024) & ($ Millions) Table 31. APAC In-vitro Toxicology Testing Market Size Market Share by Type (2019-2024) Table 32. APAC In-vitro Toxicology Testing Market Size by Application (2019-2024) & ($ Millions) Table 33. APAC In-vitro Toxicology Testing Market Size Market Share by Application (2019-2024) Table 34. Europe In-vitro Toxicology Testing Market Size by Country (2019-2024) & ($ Millions) Table 35. Europe In-vitro Toxicology Testing Market Size Market Share by Country (2019-2024) Table 36. Europe In-vitro Toxicology Testing Market Size by Type (2019-2024) & ($ Millions) Table 37. Europe In-vitro Toxicology Testing Market Size Market Share by Type (2019-2024) Table 38. Europe In-vitro Toxicology Testing Market Size by Application (2019-2024) & ($ Millions) Table 39. Europe In-vitro Toxicology Testing Market Size Market Share by Application (2019-2024) Table 40. Middle East & Africa In-vitro Toxicology Testing Market Size by Region (2019-2024) & ($ Millions) Table 41. Middle East & Africa In-vitro Toxicology Testing Market Size Market Share by Region (2019-2024) Table 42. Middle East & Africa In-vitro Toxicology Testing Market Size by Type (2019-2024) & ($ Millions) Table 43. Middle East & Africa In-vitro Toxicology Testing Market Size Market Share by Type (2019-2024) Table 44. Middle East & Africa In-vitro Toxicology Testing Market Size by Application (2019-2024) & ($ Millions) Table 45. Middle East & Africa In-vitro Toxicology Testing Market Size Market Share by Application (2019-2024) Table 46. Key Market Drivers & Growth Opportunities of In-vitro Toxicology Testing Table 47. Key Market Challenges & Risks of In-vitro Toxicology Testing Table 48. Key Industry Trends of In-vitro Toxicology Testing Table 49. Global In-vitro Toxicology Testing Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 50. Global In-vitro Toxicology Testing Market Size Market Share Forecast by Regions (2025-2030) Table 51. Global In-vitro Toxicology Testing Market Size Forecast by Type (2025-2030) & ($ Millions) Table 52. Global In-vitro Toxicology Testing Market Size Forecast by Application (2025-2030) & ($ Millions) Table 53. Abbott Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 54. Abbott In-vitro Toxicology Testing Product Offered Table 55. Abbott In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 56. Abbott Main Business Table 57. Abbott Latest Developments Table 58. Covance Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 59. Covance In-vitro Toxicology Testing Product Offered Table 60. Covance Main Business Table 61. Covance In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 62. Covance Latest Developments Table 63. GE Healthcare Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 64. GE Healthcare In-vitro Toxicology Testing Product Offered Table 65. GE Healthcare Main Business Table 66. GE Healthcare In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 67. GE Healthcare Latest Developments Table 68. Quest Diagnostics Inc. Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 69. Quest Diagnostics Inc. In-vitro Toxicology Testing Product Offered Table 70. Quest Diagnostics Inc. Main Business Table 71. Quest Diagnostics Inc. In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 72. Quest Diagnostics Inc. Latest Developments Table 73. Thermo Fisher Scientific Inc. Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 74. Thermo Fisher Scientific Inc. In-vitro Toxicology Testing Product Offered Table 75. Thermo Fisher Scientific Inc. Main Business Table 76. Thermo Fisher Scientific Inc. In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 77. Thermo Fisher Scientific Inc. Latest Developments Table 78. Bio-Rad Laboratories Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 79. Bio-Rad Laboratories In-vitro Toxicology Testing Product Offered Table 80. Bio-Rad Laboratories Main Business Table 81. Bio-Rad Laboratories In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 82. Bio-Rad Laboratories Latest Developments Table 83. Catalent Pharma Solutions Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 84. Catalent Pharma Solutions In-vitro Toxicology Testing Product Offered Table 85. Catalent Pharma Solutions Main Business Table 86. Catalent Pharma Solutions In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 87. Catalent Pharma Solutions Latest Developments Table 88. Cyprotex Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 89. Cyprotex In-vitro Toxicology Testing Product Offered Table 90. Cyprotex Main Business Table 91. Cyprotex In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 92. Cyprotex Latest Developments Table 93. Agilent Technologies Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 94. Agilent Technologies In-vitro Toxicology Testing Product Offered Table 95. Agilent Technologies Main Business Table 96. Agilent Technologies In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 97. Agilent Technologies Latest Developments Table 98. Charles River Laboratories Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 99. Charles River Laboratories In-vitro Toxicology Testing Product Offered Table 100. Charles River Laboratories Main Business Table 101. Charles River Laboratories In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 102. Charles River Laboratories Latest Developments Table 103. Merck KgaA Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 104. Merck KgaA In-vitro Toxicology Testing Product Offered Table 105. Merck KgaA In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 106. Merck KgaA Main Business Table 107. Merck KgaA Latest Developments Table 108. Eurofins Scientific Inc. Details, Company Type, In-vitro Toxicology Testing Area Served and Its Competitors Table 109. Eurofins Scientific Inc. In-vitro Toxicology Testing Product Offered Table 110. Eurofins Scientific Inc. Main Business Table 111. Eurofins Scientific Inc. In-vitro Toxicology Testing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 112. Eurofins Scientific Inc. Latest Developments

Figure 1. In-vitro Toxicology Testing Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global In-vitro Toxicology Testing Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. In-vitro Toxicology Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. In-vitro Toxicology Testing Sales Market Share by Country/Region (2023) Figure 8. In-vitro Toxicology Testing Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global In-vitro Toxicology Testing Market Size Market Share by Type in 2023 Figure 10. In-vitro Toxicology Testing in Systemic Toxicology Figure 11. Global In-vitro Toxicology Testing Market: Systemic Toxicology (2019-2024) & ($ Millions) Figure 12. In-vitro Toxicology Testing in Dermal Toxicity Figure 13. Global In-vitro Toxicology Testing Market: Dermal Toxicity (2019-2024) & ($ Millions) Figure 14. In-vitro Toxicology Testing in Endocrine Disruption Figure 15. Global In-vitro Toxicology Testing Market: Endocrine Disruption (2019-2024) & ($ Millions) Figure 16. In-vitro Toxicology Testing in Ocular Toxicity Figure 17. Global In-vitro Toxicology Testing Market: Ocular Toxicity (2019-2024) & ($ Millions) Figure 18. In-vitro Toxicology Testing in Others Figure 19. Global In-vitro Toxicology Testing Market: Others (2019-2024) & ($ Millions) Figure 20. Global In-vitro Toxicology Testing Market Size Market Share by Application in 2023 Figure 21. Global In-vitro Toxicology Testing Revenue Market Share by Player in 2023 Figure 22. Global In-vitro Toxicology Testing Market Size Market Share by Regions (2019-2024) Figure 23. Americas In-vitro Toxicology Testing Market Size 2019-2024 ($ Millions) Figure 24. APAC In-vitro Toxicology Testing Market Size 2019-2024 ($ Millions) Figure 25. Europe In-vitro Toxicology Testing Market Size 2019-2024 ($ Millions) Figure 26. Middle East & Africa In-vitro Toxicology Testing Market Size 2019-2024 ($ Millions) Figure 27. Americas In-vitro Toxicology Testing Value Market Share by Country in 2023 Figure 28. United States In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 29. Canada In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 30. Mexico In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 31. Brazil In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 32. APAC In-vitro Toxicology Testing Market Size Market Share by Region in 2023 Figure 33. APAC In-vitro Toxicology Testing Market Size Market Share by Type in 2023 Figure 34. APAC In-vitro Toxicology Testing Market Size Market Share by Application in 2023 Figure 35. China In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 36. Japan In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 37. Korea In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 38. Southeast Asia In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 39. India In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 40. Australia In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 41. Europe In-vitro Toxicology Testing Market Size Market Share by Country in 2023 Figure 42. Europe In-vitro Toxicology Testing Market Size Market Share by Type (2019-2024) Figure 43. Europe In-vitro Toxicology Testing Market Size Market Share by Application (2019-2024) Figure 44. Germany In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 45. France In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 46. UK In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 47. Italy In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 48. Russia In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 49. Middle East & Africa In-vitro Toxicology Testing Market Size Market Share by Region (2019-2024) Figure 50. Middle East & Africa In-vitro Toxicology Testing Market Size Market Share by Type (2019-2024) Figure 51. Middle East & Africa In-vitro Toxicology Testing Market Size Market Share by Application (2019-2024) Figure 52. Egypt In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 53. South Africa In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 54. Israel In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 55. Turkey In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 56. GCC Country In-vitro Toxicology Testing Market Size Growth 2019-2024 ($ Millions) Figure 57. Americas In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 58. APAC In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 59. Europe In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 60. Middle East & Africa In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 61. United States In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 62. Canada In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 63. Mexico In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 64. Brazil In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 65. China In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 66. Japan In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 67. Korea In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 68. Southeast Asia In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 69. India In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 70. Australia In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 71. Germany In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 72. France In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 73. UK In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 74. Italy In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 75. Russia In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 76. Spain In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 77. Egypt In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 78. South Africa In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 79. Israel In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 80. Turkey In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 81. GCC Countries In-vitro Toxicology Testing Market Size 2025-2030 ($ Millions) Figure 82. Global In-vitro Toxicology Testing Market Size Market Share Forecast by Type (2025-2030) Figure 83. Global In-vitro Toxicology Testing Market Size Market Share Forecast by Application (2025-2030)
Logo

Global In-vitro Toxicology Testing Market Growth (Status and Outlook) 2024-2030

Contact usWe are friendly and approachable, give us a call.